NCT05825456 Metastatic Pathologic Fractures, Short Term Results
| NCT ID | NCT05825456 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Pathologic Fracture |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-01-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single center prospective study to compare the short term results of prosthesis, nail and plate-screw surgeries for metastatic pathologic fractures.
Eligibility Criteria
Inclusion Criteria: * metastatic pathologic fracture * operated via endoprosthesis, intramedullary nail or plate \& screws Exclusion Criteria: * primary bone tumor * conservative management * neuromuscular disease * periprosthetic fractures * less than 1 month follow up
Frequently Asked Questions
Who can join the NCT05825456 clinical trial?
This trial is open to participants of all sexes, studying Pathologic Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05825456 currently recruiting?
Yes, NCT05825456 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ankara University to inquire about joining.
Where is the NCT05825456 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT05825456 clinical trial?
NCT05825456 is sponsored by Ankara University. The trial plans to enroll 200 participants.